catalym
A Senior Scientist Bioinformatics leads analysis of transcriptomic and multi-omics data from clinical trials and public datasets, translating complex data into biological insights to support biomarker discovery and patient stratification.
CatalYm is a biotechnology company pioneering the neutralization of GDF-15, a key immune resistance mechanism in cancer, to restore anti-tumor immune activity and improve responses to checkpoint inhibition. The company is developing visugromab, an immune therapy targeting solid tumors and cancer cachexia, currently advancing into Phase 2/3 clinical development. Led by an international team of experienced drug developers, CatalYm is headquartered in Planegg-Martinsried, Germany.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for catalym.
catalym didn’t post a salary, so this is our estimate from similar listings.
Bioinformatics Scientist (Postdoc)
Element Biosciences
Bioinformatics/Data Scientist
Axle
Senior Principal Scientist, Portfolio In silico Evidence Lead, Computational Biology
Digital Biology
Postdoctoral Fellow
Charterhouse
Bioinformatics Scientist-Biology
Zealand Pharma
Postdoctoral Fellow in Pediatrics
PeopleAdmin